CUPERTINO, Calif., Aug 2, 2004 /PRNewswire-FirstCall via COMTEX/ — DURECT Corporation
(Nasdaq: DRRX) announced today that it will present at the Adams, Harkness &
Hill – 24th Annual Summer Seminar. The conference is being held at the Boston
Marriott Long Wharf Hotel. Thomas A. Schreck, Chief Financial Officer, will be
presenting at the conference on Thursday, August 5, 2004 at 8:00 a.m. EDT.
A live audio webcast of Mr. Schreck’s presentation will be available by
accessing DURECT’s homepage at http://www.www.durect.com and clicking “Investor
Relations.”
DURECT Corporation (www.www.durect.com) is pioneering the development and
commercialization of pharmaceutical systems for the treatment of chronic
debilitating diseases and enabling biotechnology-based pharmaceutical
products. DURECT’s goal is to deliver the right drug to the right site in the
right amount at the right time.
SOURCE DURECT Corporation
Schond L. Greenway, Executive Director, Investor Relations and Strategic Planning of DURECT Corporation, +1-408-777-1417
http://www.www.durect.com